Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
SA |
|
B
|
Business Engineering Corp
TSE:4828
|
JP |
|
Tanaka Co Ltd
TSE:7619
|
JP |
|
K
|
Kuk Young G M
KOSDAQ:006050
|
KR |
|
A
|
Adaptive Plasma Technology Corp
KOSDAQ:089970
|
KR |
Wall Street
Price Targets
Price Targets Summary
Dr Sulaiman Al-Habib Medical Services Group Co
According to Wall Street analysts, the average 1-year price target for
Dr Sulaiman Al-Habib Medical Services Group Co
is 302.43 SAR
with a low forecast of 256.54 SAR and a high forecast of 346.5 SAR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Dr Sulaiman Al-Habib Medical Services Group Co's stock price target?
Price Target
302.43
SAR
According to Wall Street analysts, the average 1-year price target for
Dr Sulaiman Al-Habib Medical Services Group Co
is 302.43 SAR
with a low forecast of 256.54 SAR and a high forecast of 346.5 SAR.
What is Dr Sulaiman Al-Habib Medical Services Group Co's Revenue forecast?
Projected CAGR
13%
For the last 7 years the
compound annual growth rate for
Dr Sulaiman Al-Habib Medical Services Group Co's revenue is
17%.
The projected
CAGR
for the next 3 years is
13%.
What is Dr Sulaiman Al-Habib Medical Services Group Co's Operating Income forecast?
Projected CAGR
17%
For the last 7 years the
compound annual growth rate for
Dr Sulaiman Al-Habib Medical Services Group Co's operating income is
18%.
The projected
CAGR
for the next 3 years is
17%.
What is Dr Sulaiman Al-Habib Medical Services Group Co's Net Income forecast?
Projected CAGR
17%
For the last 7 years the
compound annual growth rate for
Dr Sulaiman Al-Habib Medical Services Group Co's net income is
17%.
The projected
CAGR
for the next 3 years is
17%.